跳至主要内容
临床试验/NL-OMON41555
NL-OMON41555已完成不适用

Functional magnetic resonance imaging of pancreatic cancer: a feasibility and reproducibility study - MRI of pancreatic cancer

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Patients with pancreatic tumors, with histological or cytological proof of adenocarcinoma or a high suspicion on CT imaging.
  • * Any tumor with a size * 1cm
  • * WHO-performance score 0-2
  • * Written informed consent

排除标准

  • * Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol.
  • * Contra-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non-MR compatible metallic implants in their eye, spine, thorax or abdomen; or an aneurysm clip in their brain; patients with severe claustrophobia.
  • * Renal failure (GFR < 60 ml/min) hampering safe administration of a double bolus of Gadolinium containing MR contrast agent.
  • * For the reproducibility part of the protocol: surgery, radiation and/or chemotherapy foreseen within the timeframe needed for MRI scanning.

研究者

相似试验